Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
|Articles|October 10, 2011
Conference Calendar - 2004
Author(s)OBGYN.net Staff
Advertisement
January 23–24
Paris, France
3rd European Congress for Colposcopy
June 04-06
New York, USA
8th World Congress on Computers in Gynecology, Obstetrics and Neonatology
February 02–07
New Orleans, USA
24th annual meeting Society Maternal-Fetal Medicine
February 07–11
San Diego, USA
SGO 35th Annual Meeting
June 20–21
Limasol, Cyprus
3rd World Congress in Fetal Medicine
February 26–29
Florence, Italy
11th World Congress of Gynecological Endocrinology
June 22–26
Cyprus
Advanced Course in Fetal Medicine
March 24–27
Houston, USA
Society for Gynecologic Investigation
June 23–26
Edinburgh, Scotland, UK
8th Congress of ESC
April 08–11
Kuala Lumpur, Malaysia
13th Annual Congress of the International Society for Gynecologic Endoscopy
June 27–30
Berlin, Germany
20th Annual Meeting of the ESHRE
May 12–15
Athens, Greece
The XVIIIth European Congress of Obstetrics & Gynaecology
July 06–09
Changmai, Thailand
13th International Union against Sexually Transmitted Infections
May 14–17
Fort Mayers, FL, USA
SOAP 36th Annual Meeting
September 05–09
Rio de Janeiro, Brazil
14th ISSHP World Congress
May 23–28
Montreal, Canada
IFFS 2004
October 03–07
Edinburgh, Scotland, UK
10th International Gynaecologic Cancer Society Meeting
Advertisement
Related to this article
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
Stephanie Faubion, MD, on the first menopause therapy discussion
4
Hormone therapy linked to greater migraine burden after menopause
5